What are the changes in the diagnosis of Premenstrual Dysphoric Disorder (PMDD) across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-Text Revision (TR), 4, 5, and 5-Text Revision (TR), and International Classification of Diseases (ICD) versions 10 and 11?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the changes in the diagnosis of premenstrual dysphoric disorder (PMDD) across Diagnostic and Statistical Manual of Mental Disorders (DSM) versions 3, 3-TR (Text Revision), 4, 5, and 5-TR (Text Revision), and International Classification of Diseases (ICD) versions 10 and 11?

What are the diagnosis criteria for Premenstrual Dysphoric Disorder (PMDD)?

What treatment options are available for premenstrual dysphoric disorder (PMDD) to alleviate mood swings around ovulation?

What are the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) criteria for Premenstrual Dysphoric Disorder (PMDD)?

Are there any over-the-counter (OTC) options for treating Premenstrual Dysphoric Disorder (PMDD)?

What is the recommended dose of Empagliflozin (Empagliflozin) for an adult patient with type 2 diabetes and impaired renal function?

What is the time frame in hours that defines prolonged use of Respiratory Protection Equipment (RPE)?

What are the initial medication recommendations for a patient with peripheral artery disease (PAD)?

Could a patient with swelling, heat, and pain in the back of the heel, possibly with a history of hyperuricemia or kidney stones, have gout?

What is the appropriate diagnosis and treatment for a patient presenting with a laryngocele?

What is the preferred treatment between cilostazol (phosphodiesterase inhibitor) and sulodexide (glycosaminoglycan) for a patient with peripheral artery disease (PAD) and intermittent claudication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.